Volume 131, Issue 4, Pages (October 2006)

Slides:



Advertisements
Similar presentations
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Advertisements

Daniela Sia, Augusto Villanueva, Scott L. Friedman, Josep M. Llovet 
Volume 149, Issue 4, Pages (October 2015)
Volume 146, Issue 7, Pages e3 (June 2014)
From Fat to Inflammation
Volume 152, Issue 5, Pages (April 2017)
Volume 149, Issue 4, Pages (October 2015)
Volume 150, Issue 4, Pages (April 2016)
Volume 137, Issue 3, Pages (September 2009)
Christoph Lübbert, Babett Holler  Gastroenterology 
Volume 144, Issue 5, Pages (May 2013)
Volume 151, Issue 2, Pages (August 2016)
Covering the Cover Gastroenterology
Volume 153, Issue 4, Pages (October 2017)
Outcomes Among Living Liver Donors
Daniela Sia, Augusto Villanueva, Scott L. Friedman, Josep M. Llovet 
Volume 154, Issue 3, Pages (February 2018)
Roberts Brown, Jean C. Emond  Gastroenterology 
Clinical Challenges and Images in GI
Volume 145, Issue 1, Pages (July 2013)
Volume 146, Issue 7, Pages e3 (June 2014)
Covering the Cover Gastroenterology
Volume 153, Issue 3, Pages e16-e17 (September 2017)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Leigh Ann White, Joseph Menzin, Jonathan R
Volume 141, Issue 1, Pages (July 2011)
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Volume 150, Issue 4, Pages (April 2016)
Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma  Timothy E Sawyer, MD, James A Bonner, MD, Perry M Gould,
Volume 145, Issue 1, Pages (July 2013)
Volume 155, Issue 6, Pages (December 2018)
Not Your Ordinary Ulcer: A Cautionary Tale of an Uncommon Condition
Efficient Early Drug Development for Ulcerative Colitis
High Fever After Radiofrequency Ablation of Hepatocellular Carcinoma
Volume 140, Issue 5, Pages e2 (May 2011)
Volume 133, Issue 2, Pages (August 2007)
Molecular prognostication of liver cancer: End of the beginning
Targeted Therapies for Hepatocellular Carcinoma
Recurrent Hematochezia in a Patient With Chronic Constipation
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 7, Pages (June 2015)
Volume 148, Issue 3, Pages (March 2015)
Volume 135, Issue 4, Pages (October 2008)
Shivan J. Mehta, Kimberly A. Forde  Gastroenterology 
Volume 149, Issue 6, Pages (November 2015)
The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Volume 151, Issue 4, Pages (October 2016)
Baby-Epsilon Steps Toward the Triple Aim
Volume 142, Issue 5, Pages (May 2012)
Volume 156, Issue 4, Pages (March 2019)
Long Noncoding RNAs and Hepatocellular Carcinoma
Changing of the Guards: 2011–2016 Gastroenterology Team
Liver Transplantation for Hepatocellular Carcinoma
Volume 156, Issue 3, Pages (February 2019)
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 138, Issue 6, Pages (May 2010)
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Volume 150, Issue 2, Pages (February 2016)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Issue Highlights Clinical Gastroenterology and Hepatology
Reinvesting in US Biomedical Research—The Time is Now
Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma  Jin-de Chen, Chun-jen Liu, Po-huang Lee, Pei-jer.
Volume 156, Issue 4, Pages (March 2019)
Volume 142, Issue 7, Pages (June 2012)
Genotype–Phenotype Relationships in Hepatocellular Carcinoma: p53 Inactivation Promotes Tumors With Stem Cell Features  Jean–Charles Nault, Jessica Zucman–Rossi 
Volume 141, Issue 1, Pages (July 2011)
Presentation transcript:

Volume 131, Issue 4, Pages 1262-1270 (October 2006) A Tumor Progression Model for Hepatocellular Carcinoma: Bioinformatic Analysis of Genomic Data  Terence C.W. Poon, Nathalie Wong, Paul B.S. Lai, Magnus Rattray, Philip J. Johnson, Joseph J.Y. Sung  Gastroenterology  Volume 131, Issue 4, Pages 1262-1270 (October 2006) DOI: 10.1053/j.gastro.2006.08.014 Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 1 An evolution tree for classifying the 158 HCC cases into 4 classes at 3 different evolution levels was constructed from the significant CGH events by SOTA. The class closest to the root was assigned as SOTA 1, and the 1 in the middle as SOTA 2. There were 2 classes at the bottom taxonomy level, which were grouped as SOTA 3. There were 2 subgroups A and B in the SOTA 3. Gastroenterology 2006 131, 1262-1270DOI: (10.1053/j.gastro.2006.08.014) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 2 Recurrence-free survival analysis of the HCC patients classified by SOTA. Among the 112 HCC patients who received curative tumor resection, the SOTA 3A group had a poorer recurrence-free survival compared to the SOTA 1, SOTA 2, and SOTA 3B groups. Gastroenterology 2006 131, 1262-1270DOI: (10.1053/j.gastro.2006.08.014) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 3 The frequency patterns of minimal overlapping regions of the CGH events in the 3 SOTA groups 1, 2 and 3, that potentially represent early (A), intermediate (B), and late-stage (C) events. Gastroenterology 2006 131, 1262-1270DOI: (10.1053/j.gastro.2006.08.014) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 4 Hierarchical clustering of the CGH events of SOTA 2 (A) and SOTA 3 (B). *The predicted earlier event(s) that demonstrated the highest occurrence frequency in each branch. Gastroenterology 2006 131, 1262-1270DOI: (10.1053/j.gastro.2006.08.014) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 5 Proposed evolutionary changes in the HCC carcinogenetic pathway. For chromosomal imbalances in the intermediate and late tumor stage, the minimal overlapping regions are presented. Gastroenterology 2006 131, 1262-1270DOI: (10.1053/j.gastro.2006.08.014) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 6 Overall survival (A) and recurrence-free survival (B) analyses of the HCC patients with and without gain of 3q22-24. Gastroenterology 2006 131, 1262-1270DOI: (10.1053/j.gastro.2006.08.014) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions